Here is the Resmeds commentary from 2nd quarter FY21. ASTHMA now makes it as a core market....
With this product Picture 2.. In this day and age...this is the product Resmed offers asthmatics....
Really Resmed all you can do is record someone taking there drug????
Meanwhile in land diabetes dexcom provides full monitoring and manegement cloud based information sharing.
Some catching up needed Resmed...
Here is the Resmeds commentary from 2nd quarter FY21. ASTHMA now...
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $32.85M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.1¢ | $7.357K | 234.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 496892 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 110010 | 4 |
View Market Depth
| Last trade - 15.06pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
-0.001 ( 3.13 %) |
||||
| Open | High | Low | Volume | ||
| 3.4¢ | 3.4¢ | 3.1¢ | 45929 | ||
| Last updated 14.47pm 07/05/2024 ? | |||||
| RSH (ASX) Chart |